Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026)
Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 471.36 Bn | 466.57 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 123.47 Bn | 116.22 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 8 | Argenx Se | 56.08 Bn | 50.89 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 1,997.00 |
| 10 | Arvinas | 527.36 Mn | -87.54 Mn | - | -44,679.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,679.00 |
| Dec 31, 2025 | -68,695.00 |
| Sep 30, 2025 | -4,565.00 |
| Jun 30, 2025 | -25,580.00 |
| Mar 31, 2025 | 36,707.00 |
| Dec 31, 2024 | -48,184.00 |
| Sep 30, 2024 | 15,470.00 |
| Jun 30, 2024 | 7,348.00 |
| Mar 31, 2024 | -5,940.00 |
| Dec 31, 2023 | 58,353.00 |
| Sep 30, 2023 | -1,991.00 |
| Jun 30, 2023 | 5,779.00 |
| Mar 31, 2023 | -5,211.00 |
| Dec 31, 2022 | -5,693.00 |
| Sep 30, 2022 | 31,493.00 |
| Jun 30, 2022 | 74,896.00 |
| Mar 31, 2022 | 54,045.00 |
| Dec 31, 2021 | 47,689.00 |
| Sep 30, 2021 | -9,069.00 |
| Jun 30, 2021 | -48,286.00 |